{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T15:36:33Z","timestamp":1770564993859,"version":"3.49.0"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100013795","name":"Fujian Medical University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013795","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006180","name":"Technology Development","doi-asserted-by":"publisher","award":["2023L3010"],"award-info":[{"award-number":["2023L3010"]}],"id":[{"id":"10.13039\/100006180","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cellular Signalling"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.cellsig.2025.112340","type":"journal-article","created":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T07:44:39Z","timestamp":1766389479000},"page":"112340","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Roxadustat induces erythroid differentiation of erythroleukemia cells through the hypoxia inducible factor-\u03b1\/GATA binding protein 1 axis"],"prefix":"10.1016","volume":"139","author":[{"given":"Liqing","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhehan","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jia","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuanzhong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.cellsig.2025.112340_bb0005","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1038\/leu.2013.144","article-title":"Acute erythroid leukemia (AEL) can be separated into distinct prognostic subsets based on cytogenetic and molecular genetic characteristics","volume":"27","author":"Grossmann","year":"2013","journal-title":"Leukemia"},{"issue":"4","key":"10.1016\/j.cellsig.2025.112340_bb0010","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18040837","article-title":"Clinical outcomes of 217 patients with acute Erythroleukemia according to treatment type and line: a retrospective multinational study","volume":"18","author":"Almeida","year":"2017","journal-title":"Int. J. Mol. Sci."},{"issue":"7","key":"10.1016\/j.cellsig.2025.112340_bb0015","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1038\/s41375-022-01613-1","article-title":"The 5th edition of the World Health Organization classification of Haematolymphoid Tumours: myeloid and histiocytic\/dendritic neoplasms","volume":"36","author":"Khoury","year":"2022","journal-title":"Leukemia"},{"issue":"Suppl. 4","key":"10.1016\/j.cellsig.2025.112340_bb0020","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/ajh.27659","article-title":"Emerging Pathogenetic mechanisms and new drugs for anemia in myelofibrosis and myelodysplastic syndromes","volume":"100","author":"Gangat","year":"2025","journal-title":"Am. J. Hematol."},{"issue":"16","key":"10.1016\/j.cellsig.2025.112340_bb0025","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.1182\/blood.2021011044","article-title":"Molecular and cellular mechanisms that regulate human erythropoiesis","volume":"139","author":"Caulier","year":"2022","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.cellsig.2025.112340_bb0030","doi-asserted-by":"crossref","DOI":"10.3390\/genes12101646","article-title":"Signaling pathways that regulate normal and aberrant red blood cell development","volume":"12","author":"Wilkes","year":"2021","journal-title":"Genes (Basel)"},{"issue":"21","key":"10.1016\/j.cellsig.2025.112340_bb0035","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21218131","article-title":"Hypoxia pathway proteins are master regulators of erythropoiesis","volume":"21","author":"Watts","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.cellsig.2025.112340_bb0040","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1074\/jbc.270.3.1230","article-title":"Purification and characterization of hypoxia-inducible factor 1","volume":"270","author":"Wang","year":"1995","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.cellsig.2025.112340_bb0045","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.cell.2012.01.021","article-title":"Hypoxia-inducible factors in physiology and medicine","volume":"148","author":"Semenza","year":"2012","journal-title":"Cell"},{"issue":"24","key":"10.1016\/j.cellsig.2025.112340_bb0050","doi-asserted-by":"crossref","first-page":"9361","DOI":"10.1128\/MCB.23.24.9361-9374.2003","article-title":"Differential roles of hypoxia-inducible factor 1alpha (HIF-1alpha) and HIF-2alpha in hypoxic gene regulation","volume":"23","author":"Hu","year":"2003","journal-title":"Mol. Cell. Biol."},{"issue":"2","key":"10.1016\/j.cellsig.2025.112340_bb0055","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1002\/med.21527","article-title":"Erythropoiesis and chronic kidney disease-related anemia: from physiology to new therapeutic advancements","volume":"39","author":"Cernaro","year":"2019","journal-title":"Med. Res. Rev."},{"issue":"1","key":"10.1016\/j.cellsig.2025.112340_bb0060","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/s41419-018-1274-6","article-title":"Erythropoietin inhibits chemotherapy-induced cell death and promotes a senescence-like state in leukemia cells","volume":"10","author":"Pham","year":"2019","journal-title":"Cell Death Dis."},{"issue":"9","key":"10.1016\/j.cellsig.2025.112340_bb0065","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.6004\/jnccn.2022.0046","article-title":"Myeloproliferative neoplasms, version 3.2022, NCCN clinical practice guidelines in oncology","volume":"20","author":"Gerds","year":"2022","journal-title":"J. Natl. Compr. Cancer Netw."},{"issue":"6","key":"10.1016\/j.cellsig.2025.112340_bb0070","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1007\/s11864-024-01217-0","article-title":"Treatment of anemia in lower-risk myelodysplastic syndrome","volume":"25","author":"Battaglia","year":"2024","journal-title":"Curr. Treat. Options in Oncol."},{"key":"10.1016\/j.cellsig.2025.112340_bb0075","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.brainres.2015.12.017","article-title":"Stabilization of HIF-1alpha by FG-4592 promotes functional recovery and neural protection in experimental spinal cord injury","volume":"1632","author":"Wu","year":"2016","journal-title":"Brain Res."},{"key":"10.1016\/j.cellsig.2025.112340_bb0080","doi-asserted-by":"crossref","first-page":"1503477","DOI":"10.3389\/fcell.2025.1503477","article-title":"Roxadustat regulates the cell cycle and inhibits proliferation of mesangial cells via the hypoxia-inducible factor-1alpha\/P53\/P21 pathway","volume":"13","author":"Cheng","year":"2025","journal-title":"Front. Cell Dev. Biol."},{"issue":"11","key":"10.1016\/j.cellsig.2025.112340_bb0085","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202317810","article-title":"The transcription factor HIF2alpha partakes in the differentiation block of acute myeloid leukemia","volume":"15","author":"Magliulo","year":"2023","journal-title":"EMBO Mol. Med."},{"issue":"10","key":"10.1016\/j.cellsig.2025.112340_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2023.107804","article-title":"GATA1 deletion in human pluripotent stem cells increases differentiation yield and maturity of neutrophils","volume":"26","author":"Harper","year":"2023","journal-title":"iScience"},{"issue":"1","key":"10.1016\/j.cellsig.2025.112340_bb0095","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.exphem.2007.08.014","article-title":"Hypoxia alters progression of the erythroid program","volume":"36","author":"Rogers","year":"2008","journal-title":"Exp. Hematol."},{"issue":"7","key":"10.1016\/j.cellsig.2025.112340_bb0100","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1172\/JCI0215686","article-title":"The gene encoding the iron regulatory peptide hepcidin is regulated by anemia, hypoxia, and inflammation","volume":"110","author":"Nicolas","year":"2002","journal-title":"J. Clin. Invest."},{"issue":"4","key":"10.1016\/j.cellsig.2025.112340_bb0105","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1038\/s41375-019-0629-z","article-title":"Hypoxia-inducible factor 1 (HIF-1) is a new therapeutic target in JAK2V617F-positive myeloproliferative neoplasms","volume":"34","author":"Baumeister","year":"2020","journal-title":"Leukemia"},{"issue":"1","key":"10.1016\/j.cellsig.2025.112340_bb0110","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1038\/s41392-022-01080-1","article-title":"Hypoxia signaling in human health and diseases: implications and prospects for therapeutics","volume":"7","author":"Luo","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"issue":"8","key":"10.1016\/j.cellsig.2025.112340_bb0115","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1111\/j.1582-4934.2011.01484.x","article-title":"Hypoxia-inducible factor 1-mediated human GATA1 induction promotes erythroid differentiation under hypoxic conditions","volume":"16","author":"Zhang","year":"2012","journal-title":"J. Cell. Mol. Med."},{"issue":"10","key":"10.1016\/j.cellsig.2025.112340_bb0120","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202001044RRR","article-title":"Meis1, Hi1alpha, and GATA1 are integrated into a hierarchical regulatory network to mediate primitive erythropoiesis","volume":"35","author":"Chung","year":"2021","journal-title":"FASEB J."},{"issue":"22","key":"10.1016\/j.cellsig.2025.112340_bb0125","article-title":"Zebrafish Hif3alpha modulates erythropoiesis via regulation of gata1 to facilitate hypoxia tolerance","volume":"147","author":"Cai","year":"2020","journal-title":"Development"},{"issue":"9","key":"10.1016\/j.cellsig.2025.112340_bb0130","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1002\/ajh.27410","article-title":"Roxadustat versus placebo for patients with lower-risk myelodysplastic syndrome: MATTERHORN phase 3, double-blind, randomized controlled trial","volume":"99","author":"Mittelman","year":"2024","journal-title":"Am. J. Hematol."},{"issue":"5","key":"10.1016\/j.cellsig.2025.112340_bb0135","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1002\/ajh.26865","article-title":"Open-label, phase 2 study of roxadustat for the treatment of anemia in patients receiving chemotherapy for non-myeloid malignancies","volume":"98","author":"Glaspy","year":"2023","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.cellsig.2025.112340_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2025.117999","article-title":"The hypoxia signaling pathway in the development of acute myeloid leukemia","volume":"186","author":"Yang","year":"2025","journal-title":"Biomed. Pharmacother."},{"issue":"2","key":"10.1016\/j.cellsig.2025.112340_bb0145","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.blre.2017.09.002","article-title":"Erythroleukemia-historical perspectives and recent advances in diagnosis and management","volume":"32","author":"Boddu","year":"2018","journal-title":"Blood Rev."},{"issue":"1","key":"10.1016\/j.cellsig.2025.112340_bb0150","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1002\/iub.2192","article-title":"Regulation of GATA1 levels in erythropoiesis","volume":"72","author":"Gutierrez","year":"2020","journal-title":"IUBMB Life"},{"issue":"1","key":"10.1016\/j.cellsig.2025.112340_bb0155","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.blre.2012.12.003","article-title":"Regulation of erythropoiesis by hypoxia-inducible factors","volume":"27","author":"Haase","year":"2013","journal-title":"Blood Rev."},{"issue":"12","key":"10.1016\/j.cellsig.2025.112340_bb0160","doi-asserted-by":"crossref","first-page":"4635","DOI":"10.1172\/JCI63924","article-title":"Hypoxia-inducible factor regulates hepcidin via erythropoietin-induced erythropoiesis","volume":"122","author":"Liu","year":"2012","journal-title":"J. Clin. Invest."},{"issue":"6","key":"10.1016\/j.cellsig.2025.112340_bb0165","doi-asserted-by":"crossref","first-page":"4090","DOI":"10.1074\/jbc.M110.173096","article-title":"Regulation of type II transmembrane serine proteinase TMPRSS6 by hypoxia-inducible factors: new link between hypoxia signaling and iron homeostasis","volume":"286","author":"Lakhal","year":"2011","journal-title":"J. Biol. Chem."},{"issue":"12","key":"10.1016\/j.cellsig.2025.112340_bb0170","doi-asserted-by":"crossref","first-page":"5727","DOI":"10.1182\/blood-2007-08-106195","article-title":"Erythropoietin mediates hepcidin expression in hepatocytes through EPOR signaling and regulation of C\/EBPalpha","volume":"111","author":"Pinto","year":"2008","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.cellsig.2025.112340_bb0175","article-title":"Activation of intestinal HIF2alpha ameliorates iron-refractory anemia","volume":"11","author":"Yu","year":"2024","journal-title":"Adv. Sci. (Weinh.)"},{"issue":"15","key":"10.1016\/j.cellsig.2025.112340_bb0180","doi-asserted-by":"crossref","first-page":"3793","DOI":"10.1182\/bloodadvances.2023009798","article-title":"Drugs activating hypoxia-inducible factors correct erythropoiesis and hepcidin levels via renal EPO induction in mice","volume":"7","author":"Nakai","year":"2023","journal-title":"Blood Adv."},{"issue":"4","key":"10.1016\/j.cellsig.2025.112340_bb0185","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1111\/bjh.12649","article-title":"The transcription factor ATOH8 is regulated by erythropoietic activity and regulates HAMP transcription and cellular pSMAD1,5,8 levels","volume":"164","author":"Patel","year":"2014","journal-title":"Br. J. Haematol."},{"issue":"7","key":"10.1016\/j.cellsig.2025.112340_bb0190","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1182\/blood.2019004017","article-title":"How I treat cancer-associated anemia","volume":"136","author":"Gilreath","year":"2020","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.cellsig.2025.112340_bb0195","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1074\/jbc.M116.749465","article-title":"Three tyrosine residues in the erythropoietin receptor are essential for Janus Kinase 2 V617F mutant-induced tumorigenesis","volume":"292","author":"Ueda","year":"2017","journal-title":"J. Biol. Chem."},{"issue":"12","key":"10.1016\/j.cellsig.2025.112340_bb0200","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1038\/leu.2015.156","article-title":"Loss of HIF-1alpha accelerates murine FLT-3(ITD)-induced myeloproliferative neoplasia","volume":"29","author":"Velasco-Hernandez","year":"2015","journal-title":"Leukemia"},{"issue":"1","key":"10.1016\/j.cellsig.2025.112340_bb0205","doi-asserted-by":"crossref","DOI":"10.3390\/cancers16010154","article-title":"ACVR1: a novel therapeutic target to treat anemia in myelofibrosis","volume":"16","author":"Duminuco","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"4","key":"10.1016\/j.cellsig.2025.112340_bb0210","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1038\/nm.3512","article-title":"Transforming growth factor-beta superfamily ligand trap ACE-536 corrects anemia by promoting late-stage erythropoiesis","volume":"20","author":"Suragani","year":"2014","journal-title":"Nat. Med."},{"issue":"12","key":"10.1016\/j.cellsig.2025.112340_bb0215","doi-asserted-by":"crossref","first-page":"3435","DOI":"10.1182\/blood-2010-07-295550","article-title":"HIF1alpha synergizes with glucocorticoids to promote BFU-E progenitor self-renewal","volume":"117","author":"Flygare","year":"2011","journal-title":"Blood"}],"container-title":["Cellular Signalling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0898656825007557?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0898656825007557?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T19:56:49Z","timestamp":1770494209000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0898656825007557"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":43,"alternative-id":["S0898656825007557"],"URL":"https:\/\/doi.org\/10.1016\/j.cellsig.2025.112340","relation":{},"ISSN":["0898-6568"],"issn-type":[{"value":"0898-6568","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Roxadustat induces erythroid differentiation of erythroleukemia cells through the hypoxia inducible factor-\u03b1\/GATA binding protein 1 axis","name":"articletitle","label":"Article Title"},{"value":"Cellular Signalling","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cellsig.2025.112340","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"112340"}}